This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.

Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Ophthalmology
Ophthalmology
Respiratory
Respiratory
Bayer for ProfessionalsYour Resource Portal

Risk Minimisation Materials

PP-PF-OTH-GB-0119 | October 2025

Please click on the product logo's below to be taken to the relevant Risk Minimisation Materials.

Eylea® (aflibercept) 2mg

EYLEA® Prescribing Information

Eylea® (aflibercept) 8mg

EYLEA® Prescribing Information

Jaydess®▼

(13.5mg intrauterine delivery system levonorgestrel)

Jaydess® Prescribing Information

Kerendia®▼ (finerenone)​

Kerendia® Prescribing Information

Kyleena®

(19.5mg intrauterine delivery system levonorgestrel)

Kyleena® Prescribing Information

Mirena®

(52mg intrauterine delivery system levonorgestrel)

Mirena® Prescribing Information

Qlaira® (estradiol valerate/dienogest)

Qlaira® Prescribing information

Xarelto® (Rivaroxaban)

Xarelto® Prescribing Information

PP-PF-OTH-GB-0119 | October 2025